Pathway Financial Advisers’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.5M Sell
18,393
-657
-3% -$153K 1.27% 21
2025
Q4
$3.94M Sell
19,050
-232
-1% -$45.9K 1.14% 27
2025
Q3
$3.56M Sell
19,282
-1
-0% -$171 1.04% 31
2025
Q2
$2.95M Sell
19,283
-25
-0.1% -$3.84K 0.95% 35
2025
Q1
$3.2M Sell
19,308
-830
-4% -$130K 1.1% 34
2024
Q4
$2.91M Buy
20,138
+89
+0.4% +$13.8K 0.98% 32
2024
Q3
$3.25M Sell
20,049
-114
-0.6% -$18.2K 1.47% 22
2024
Q2
$2.93M Sell
20,163
-236
-1% -$35.1K 1.05% 31
2024
Q1
$3.23M Sell
20,399
-410
-2% -$65.3K 1.16% 25
2023
Q4
$3.26M Sell
20,809
-196
-0.9% -$30.1K 1.24% 23
2023
Q3
$3.27M Buy
+21,005
New +$3.47M 1.35% 19
2023
Q1
$3.27M Sell
21,085
-71
-0.3% -$11.5K 1.31% 20
2022
Q4
$3.74M Buy
+21,156
New +$3.65M 1.52% 15

Other funds holding JNJ

Pathway Financial Advisers's JNJ Position: Q1 2026 in Review

Pathway Financial Advisers reduced its Johnson & Johnson (JNJ) stake by 3.4% in Q1 2026, selling an estimated $153K and leaving 18,393 shares worth $4.5M. The position accounts for 1.27% of the portfolio, ranked #21.

Pathway Financial Advisers first reported a position in JNJ in Q4 2022 and has held it in 13 quarters since. 4,613 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Pathway Financial Advisers held 18,393 shares of Johnson & Johnson worth $4.5M as of Q1 2026.
  • Pathway Financial Advisers sold 657 Johnson & Johnson shares in Q1 2026, an estimated $153K.
  • Johnson & Johnson made up 1.27% of Pathway Financial Advisers's portfolio in Q1 2026, its #21 holding.
  • Pathway Financial Advisers first reported a position in Johnson & Johnson in Q4 2022 and has held it in 13 quarters since.
  • 4,613 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Pathway Financial Advisers's 13F filing for Q1 2026, filed 23 Apr 2026.